Document Details

MGEN $0.76 $ + 0.09 (14.24%)
Document Details

Filing Type

8-K (SEC's EDGAR System)

Company Miragen Therapeutics (Boulder, CO)
Event Date 10/31/2019
Filing Date 10/31/2019

Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Entry into a Material Definitive Agreement; Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing; Unregistered Sales of Equity Securities; and Financial Statements and Exhibits.

File Section(s)

  1. FORM 8K
  2. EXHIBIT 10.1

Note: This document was filed with the SEC in HTML format, as allowed by the recent EDGAR system modernization. S&P cannot take responsibility for its appearance, layout, or legibility.